India’s Bioeconomy Reaches $195 Billion in 2025, Up From $10 Billion in 2014

India’s bioeconomy has expanded significantly over the past decade, reaching over $195 billion in 2025 from about $10 billion in 2014. The update was shared by Union Minister Dr Jitendra Singh during BIRAC’s 14th Foundation Day event in New Delhi.

The sector recorded annual growth of around 17–18% in the last year, rising from approximately $165 billion to $195 billion. This growth reflects India’s increasing role as a global biotechnology hub.

Bioeconomy Growth and Key Metrics

India’s bioeconomy has demonstrated sustained expansion, supported by innovation and sectoral diversification. The India Bioeconomy Report 2026 estimates the sector size at $195.3 billion in 2025. The sector now contributes approximately 4.8% to the national GDP.

Key growth indicators include:

• Market size: $195.3 billion in 2025
• Growth from 2014: $10 billion to $195 billion
• CAGR: Nearly 18%
• GDP contribution: 4.8%

The sector has more than doubled in size since 2020, indicating accelerated momentum. This expansion is aligned with increasing demand for biotech-driven solutions across industries.

Role of BIRAC in Innovation Ecosystem

The Biotechnology Industry Research Assistance Council has played a key role in advancing India’s biotechnology ecosystem by fostering collaboration between research institutions and industry. It provides support through funding, incubation and mentorship programmes.

Its initiatives have supported over 11,800 biotech startups, enabled commercialisation of research and promoted industry-academia partnerships. The BIRAC Impact Report highlights measurable progress in product development, startup growth and broader societal impact through innovation-driven solutions.

Policy Support and Strategic Initiatives

Government policy initiatives are supporting the expansion of India’s biotechnology sector, with the BioE3 Policy focusing on economy, environment and employment. The policy promotes innovation across healthcare, agriculture and sustainability domains.

Priority areas include precision biotherapeutics, smart proteins, climate-resilient agriculture, bio-based chemicals and carbon capture technologies. Additionally, the ₹1 lakh crore Research, Development and Innovation Fund has been introduced, with BIRAC playing a key role in deploying capital to scale biotechnology ventures.

Investment, Employment and Skill Development

The growth of the bioeconomy is expected to generate employment and require large-scale skill development. The sector is supported by a strong base of scientists, entrepreneurs, and startups. Focus has also been placed on expanding participation from tier-2 and tier-3 cities.

Key employment and ecosystem trends include:

The government is emphasising training, inclusion of women entrepreneurs, and development of young scientific talent. These efforts aim to build a broad-based innovation ecosystem across regions.

Read More: Centre Lines Up Projects for Green Bond Funding in FY27

Conclusion

India’s bioeconomy has grown from $10 billion in 2014 to over $195 billion in 2025, reflecting sustained expansion. The sector’s contribution to GDP and its rapid growth rate indicate increasing economic relevance.

Institutional support from BIRAC and policy initiatives such as the BioE3 framework and RDI Fund have supported this progress. The ecosystem now includes thousands of startups and a growing innovation pipeline.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.